Analysis Supernus Pharmaceuticals Inc (SUPN)
6/3/2024
Analysis of Supernus Pharmaceuticals Inc (SUPN)
Supernus Pharmaceuticals Inc (SUPN) has been showing a downward trend in the recent days. The Relative Strength Index (RSI) values have been below 50, indicating a bearish momentum. The Moving Average Convergence Divergence (MACD) indicator has been negative, with the MACD line consistently below the signal line.The stock prices have been below the Moving Averages (SMA, EMA, WMA), suggesting a bearish sentiment in the market. The stock closed at $27.12 on the latest trading day, which is lower than the previous days.
Overall, based on the technical indicators, Supernus Pharmaceuticals Inc seems to be in a bearish phase. Traders and investors may consider exercising caution or implementing risk management strategies when dealing with this stock.
Income statement 💸
Here are the revenue figures for the given fiscal years:- 2023: $383,285,000,000
- 2022: $394,328,000,000
- 2021: $365,817,000,000
- 2020: $274,515,000,000
From these numbers, we can observe that the company's revenue has been increasing over the years, with a significant jump from 2020 to 2021, followed by a slight decrease in 2023 compared to 2022. This trend indicates a general growth in the company's top line, although there may have been fluctuations in certain years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist mainly of investments and advances, with a significant portion in machinery, furniture, and equipment.
4. Total liabilities have also been increasing, with a slight decrease in 2019 compared to 2018.
5. Current liabilities include short-term debt, accounts payable, and other current liabilities.
6. Non-current liabilities consist of long-term debt and other non-current liabilities.
7. Shareholders' equity has shown an overall increasing trend, with common stock and retained earnings being the major components.
8. The company seems to be in a stable financial position with a healthy balance between assets, liabilities, and equity.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow. The balance sheet shows a positive current ratio, but a high total debt to equity ratio. The profit margin and operating margin are both healthy, indicating efficient operations. The company's fiscal year ends in September 2023, with notable figures such as EBITDA, revenue, and net income.
Moving on to stock statistics, key metrics include short ratio, float shares, shares outstanding, and insider and institutional ownership percentages. The company's stock price summary highlights beta, moving averages, and the range of the stock price over the past year.
Valuation metrics provide insights into the company's valuation multiples such as P/E ratio, PEG ratio, price to book, and price to sales ratios. The enterprise value, market capitalization, and other valuation indicators are also included.
Lastly, dividends and splits information details the company's dividend history, payout ratio, dividend dates, and dividend yields. The last split date and factor are mentioned, along with the forward annual dividend rate and 5-year average dividend yield.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. The EPS estimate is also higher than the $1.35 EPS from the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a slight increase from the EPS of $6.10 for the current year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The growth rate for the current quarter is estimated to be 5.1%.
2. Next Quarter: The growth rate for the next quarter is estimated to be slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate for the next year is expected to increase to 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is relatively high at 20.1%.
6. Next 5 Years (per annum): Looking ahead, the average annual growth rate for the next 5 years is estimated to be 9.7%.
Overall, the company is expected to experience a significant growth rate in the upcoming years compared to the past 5 years, with a particularly strong growth forecast for the next year.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty in the predictions. Investors should consider these factors when making decisions about buying or selling the security.
MACD of SUPN
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
